Rosuvastatin decreases serum inflammatory markers and slows atherosclerosis progression rate in treated HIV-infected patients with metabolic syndrome

.

Source: Infectious Diseases - September 20, 2020 Category: Infectious Diseases Authors: Leonardo Calza Vincenzo Colangeli Marco Borderi Giacomo Beci Fabio Esposito Isabella Bon Maria Carla Re Pierluigi Viale Source Type: research